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Background/introduction
Radio frequency induced thalamotomy has been used in
patients with neuropathic pain for many years. Today,
transcranial MR imaging-guided focused ultrasound
(tcMRIgFUS) offers the opportunity to conduct this
treatment non-invasively under closed-loop MR-imaging
guidance.
Methods
So far we have treated a total of 23 patients suffering
from chronic neuropathic pain of various origins using
tcMRIgFUS. Targeting the posterior part of the central
lateral nucleus of the thalamus (pCL), we applied both
unilateral and bilateral lesions, depending on the severity
and extent of the clinical symptoms. Also, depending on
clinical presentation, the effected lesions were created
either by a single ablation cell, or, where the lesion
volume of a single ablation cell seemed insufficient, by
combining two to three adjoining ablation cells that were
generated by electronically steering the acoustic focus a
few millimetres in order to increase the lesion volume.
Using a custom built eight channel phased array coil
which snugly fits around the ultrasound transducer, high
resolution images could be acquired during the whole
intervention procedure. The temperature evolution in the
target region was continuously monitored by MR-ther-
mometry and therapeutically effective temperatures were
considered to lie between 54 and 62°C.
Results and conclusions
Long term effects resulting from pCL thalamotomy with
tcMRIgFUS in the 23 patients evaluated here during a
follow-up period of 1 to 2 years will be presented. The
median pain relief is 56%, with an average reduction of
subjectively felt maximal pain intensity of 34% estimated
by the patients on a numerical rating scale. Here we will
present important physical parameters such as lesion
size and its evolution over time, as well as maximal tem-
perature achieved during the FUS intervention. We will
demonstrate the relationship between therapeutic effect
and lesion size and Tmax, respectively. Apart from the
pain relief, changes in quality of life and activity of daily
living are at least as important for the patients. The
results will also demonstrate the mutual compliment of
deep brain stimulation and focused ultrasound. They
form the basis for discussing possible improvements in
patient management and new methodological approaches
in order to allow application of tcMRIgFUS also in diffi-
cult and desperate patient situations.
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